UW-CTRI Triple Medication Smoking Cessation Study

NCT02681510 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Smoking

Interventions

DRUG: Varenicline
DRUG: Nicotine Transdermal Patch
DRUG: Nicotine Mini

Sponsor

University of Wisconsin, Madison